Convenience Comparison Study of Reconstitution Devices for the Blood Coagulation Factor VIII Products Rurioctocog Alfa Pegol and Antihemophilic Factor (Recombinant)

por Ueda, Hitoshi, Toyoda, Misato, Arai, Morio, Sakai, Michio
Publicado 2020

Postmarketing safety and effectiveness of recombinant factor IX (nonacog alfa) in Japanese patients with haemophilia B

por Fukutake, Katsuyuki, Taki, Masashi, Matsushita, Tadashi, Sakai, Michio, Takata, Ami, Yamaguchi, Hiromi, Karumori, Toshiyuki
Publicado 2019

Burden of congenital hemophilia A requiring treatment in Japan: The HIKOBOSHI study

por Nagao, Azusa, Ioka, Akiko, Nakamura, Takao, Murakami, Yoichi, Makishima, Misako, Okada, Norihiro, Sakai, Michio
Publicado 2022

The seroprevalence of neutralizing antibodies against the adeno-associated virus capsids in Japanese hemophiliacs

por Kashiwakura, Yuji, Baatartsogt, Nemekhbayar, Yamazaki, Shoji, Nagao, Azusa, Amano, Kagehiro, Suzuki, Nobuaki, Matsushita, Tadashi, Sawada, Akihiro, Higasa, Satoshi, Yamasaki, Naoya, Fujii, Teruhisa, Ogura, Taemi, Takedani, Hideyuki, Taki, Masashi, Matsumoto, Takeshi, Yamanouchi, Jun, Sakai, Michio, Nishikawa, Masako, Yatomi, Yutaka, Yada, Koji, Nogami, Keiji, Watano, Ryota, Hiramoto, Takafumi, Hayakawa, Morisada, Kamoshita, Nobuhiko, Kume, Akihiro, Mizukami, Hiroaki, Ishikawa, Shizukiyo, Sakata, Yoichi, Ohmori, Tsukasa
Publicado 2022